Baird Raises Thermo Fisher Scientific (TMO) Price Target to $756
Key Points
- Baird reiterated its Outperform rating on Thermo Fisher Scientific Inc. on October 22, 2026, lifting its price target to $756 from $723.
- Baird's $756 price target implies 8.93% upside from Thermo Fisher Scientific Inc.'s ($TMO) current $694.02 share price.
- The company reported trailing-twelve-month revenue of $47.35 billion with a net margin of 14.9%, and its next earnings report is set for January 28, 2027.
- Wall Street maintains a strong buy consensus on the stock, with a mean price target of $706.69 across 26 analyst opinions.
Get Thermo Fisher Scientific text alerts
We text you when insiders, Congress, analysts or big funds move on $TMO.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Thermo Fisher Scientific Inc. alert may contain errors. Disclosures
On October 22, 2026, Baird reiterated its Outperform rating on Thermo Fisher Scientific Inc. (NYSE: TMO) while lifting its price target to $756 from $723. The research note was issued on the same day the stock closed at $694.02 on October 21, 2026.
TMO
Thermo Fisher Scientific Inc.
Baird vs. the S&P 500
Hypothetical returns from Baird's disclosed trades, not real profit or advice. How we model this.
Baird's Call on Thermo Fisher Scientific
Baird's updated target of $756 sits above the stock's recent price of $694.02 on October 22, 2026. Prior to this update, other firms weighed in on the diagnostics and research provider. On September 3, 2026, CLSA initiated coverage with an Outperform rating and a $748 target. Later, on October 7, 2026, Barclays maintained its Overweight rating and raised its target to $750 from $650. Morgan Stanley followed on October 13, 2026, keeping an Overweight rating while lifting its target to $730 from $650. On the same day, TD Cowen maintained a Buy rating and raised its target to $760 from $675.
Other Institutional Activity in Thermo Fisher Scientific Inc.
Large funds continue to adjust their holdings in the life sciences provider. ASR Vermogensbeheer N.V. reduced its stake by 58,988 shares in a report dated October 16, 2026, ending with 34,721 shares valued at about $23.44 million. Quilter grew its holdings by 3,378 shares in a report dated October 21, 2026, holding 314,588 shares worth roughly $212.36 million. In an earlier filing for the quarter ended June 30, 2026, Franklin Resources, Inc. added 458,515 shares to finish with 7,271,514 shares valued at approximately $5.05 billion.
Thermo Fisher Scientific Inc. Stock Up 1.0%
The shares recently traded around $694.02 as of October 22, 2026. The stock closed at $694.02 on October 21, 2026.
$TMO price target
Thermo Fisher Scientific Inc. daily closes and this analyst's $756 target. Not advice.
Recent Earnings
The firm recorded trailing-twelve-month revenue of $47.35 billion with basic earnings per share of $18.96. Profitability metrics include a net margin of 14.9% and a return on equity of 13.4%. The next quarterly earnings update is scheduled for January 28, 2027.
Dividend
The company pays an annual dividend of $1.88 per share, yielding 0.27% with a payout ratio of 9.7%.
Insider Buying and Selling at Thermo Fisher Scientific Inc.
Company insiders executed several transactions prior to the analyst update. On August 19, 2026, officer Lisa P Britt sold 11,440 shares at an average price of $613.12 for a total of $7.01 million. Chief Executive Officer Marc N Casper sold 20,000 shares on August 21, 2026, valued at $12.56 million, and later sold 275 shares on August 24, 2026, for $172,439. Additionally, president Gianluca Pettiti sold 4,133 shares on August 31, 2026, at an average price of $614.38, totaling $2.54 million.
Analysts Set New Price Targets
Analyst sentiment remains broadly positive across the sector. The stock currently holds a consensus recommendation of strong buy from 26 analysts, accompanied by a mean price target of $706.69.
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. provides analytical instruments, life sciences solutions, specialty diagnostics, and laboratory products. Headquartered in Waltham, Massachusetts, and employing 125,000 people, the company serves biopharma, healthcare, and research markets globally.
Bottom Line
Investors will look toward Thermo Fisher's next earnings report on January 28, 2027, for further insight into revenue trends. Market participants continue to monitor how shares trade relative to analyst consensus targets.
Related Filing Alerts
Source: Baird's rating change on $TMO (Oct 22, 2026). Written by software, not financial advice. How we make alerts